Latest Mesenchymal stem cell Stories
HONOLULU, April 19, 2011 /PRNewswire/ -- Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care. The clinical...
A type of adult stem cell is now proving itself more versatile for research and therapies thanks to revolutionary 3D experiments. These cells have already shown great promise for repairing damaged bone and cartilage but until now have been fairly limited in the types of cells they can form in the laboratory.Dr Paul Genever from the University of York will be speaking later today (31 March) at the annual UK National Stem Cell Network science meeting. He will tell the gathered audience of...
BOSTON, March 28, 2011 /PRNewswire/ -- For over 15 years now, parents have had the option to save the blood that is found within their baby's umbilical cord immediately following birth. The blood is rich in hematopoietic stem cells (HSC's). These multipotent stem cells have the ability to give rise to all blood cell types. Parents have the peace of mind of knowing that their child, and perhaps siblings and other family members, could in fact use these cells as part of a curative treatment...
(Ivanhoe Newswire) "“ It's been shown for the first time that stem cells injected into enlarged hearts reduced hear size, reduced scar tissue, and improved function to injured heart areas, according to this human trial.The researchers believe that the findings are promising for the more than five million Americans who have enlarged hearts due to damage sustained from heart attacks. Patients with enlarged hearts can suffer premature death, have major disability, and experience frequent...
A fibroblast is not always just a fibroblast "“ particularly in the heart.In a heart attack, fibroblasts "“ special repair cells that form a scar after injury "“ come from a population of stem cells that reside within the heart, said researchers from Baylor College of Medicine and the Methodist Hospital in a report that appears in the journal Cardiovascular Research. By contrast, earlier work showed that the fibroblasts responsible for fibrosis "“ excess fibrous connective tissue "“...
Researchers have shown for the first time that stem cells injected into enlarged hearts reduced heart size, reduced scar tissue and improved function to injured heart areas, according to a small trial published in Circulation Research: Journal of the American Heart Association.Researchers said that while this research is in the early stages, the findings are promising for the more than five million Americans who have enlarged hearts due to damage sustained from heart attacks. These patients...
CARLSBAD, Calif., March. 14, 2011 /PRNewswire/ -- Life Technologies Corporation (Nasdaq: LIFE) today announced it has received FDA 510(k) clearance for StemPro® MSC SFM - a first for this next-generation stem cell culture medium that is now cleared as a medical device and satisfies a crucial requirement for researchers involved in clinical trials in the United States. (Photo: http://photos.prnewswire.com/prnh/20110314/LA64069) (Logo:...
Stemedica announced today that it has received Institutional Review Board (IRB) approval from the University of California, San Diego (UCSD) to initiate a Stemedica clinical study entitled, "A Phase I/II, Multi-Center, Open-Label Study to Assess the Safety, Tolerability and Preliminary Efficacy of a Single Intravenous Dose of Allogeneic Mesenchymal Bone Marrow Cells to Subjects With Ischemic Stroke". San Diego, CA (PRWEB) February 17, 2011 Stemedica Cell Technologies, Inc., a...
Stem Cell scientists in Australia have found that patients suffering from hearing problems which began during infancy and childhood could benefit from a transplant of stem cells from their nose. The research, published today in STEM CELLS, reveals that mucosa-derived stem cells can help preserve hearing function during the early-onset of sensorineural hearing loss.Sensorineural hearing loss is caused by the loss of sensory cells or neurons in the cochlea, the sensory organ of the inner ear...
Successful intranasal delivery of stem cells to the brains of rats with Parkinson disease yielded significant improvement in motor function and reversed the dopamine deficiency characteristic of the disease. These highly promising findings, reported in Rejuvenation Research, a peer-reviewed journal published by Mary Ann Liebert, Inc. highlight the potential for a noninvasive approach to cell therapy delivery in Parkinson disease"“a safer and effective alternative to surgical transplantation...
